Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2209 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 92.76 USD | -0.64% | -6.59% | -20.97% | +15.12% | 1.37 B USD | ||
| 2211 |  AAPG Ascentage Pharma Group International - American Depository Shar | 14.55 USD | -4.09% | -4.59% | -15.55% | -41.80% | 1.36 B USD | ||
| 2218 |  ANAB AnaptysBio, Inc. - Common Stock | 46.21 USD | +1.23% | -5.64% | -16.87% | +31.28% | 1.34 B USD | ||
| 2244 |  GHRS GH Research PLC - Ordinary Shares | 20.45 USD | -2.90% | -11.28% | -26.36% | +44.42% | 1.27 B USD | ||
| 2253 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 12.03 USD | +0.17% | -5.42% | -3.76% | -10.95% | 1.25 B USD | ||
| 2262 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.00 USD | -1.75% | -4.96% | -4.76% | +226.34% | 1.23 B USD | ||
| 2265 |  REPL Replimune Group, Inc. - Common Stock | 13.04 USD | -1.21% | -4.75% | -10.19% | +184.72% | 1.23 B USD | ||
| 2277 |  TYRA Tyra Biosciences, Inc. - Common Stock | 19.97 USD | -2.06% | -6.02% | +5.44% | +39.26% | 1.19 B USD | ||
| 2302 |  BCAX Bicara Therapeutics Inc. - Common Stock | 17.26 USD | +5.12% | -5.37% | -26.14% | +19.53% | 1.14 B USD | ||
| 2310 |  VOR Vor Biopharma Inc. - Common Stock | 19.13 USD | +1.86% | +5.75% | -21.82% | +46.03% | 1.13 B USD | ||
| 2311 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.50 USD | +3.24% | +7.25% | -7.22% | -23.96% | 1.13 B USD | ||
| 2321 |  LBRX LB Pharmaceuticals Inc - Common Stock | 34.61 USD | +1.32% | -8.24% | -29.47% | +130.58% | 1.12 B USD | ||
| 2330 |  NBTX Nanobiotix S.A. - ADSs | 22.90 USD | -6.99% | -16.39% | -35.40% | -13.75% | 1.11 B USD | ||
| 2332 |  MNKD MannKind Corporation - Common Stock | 3.42 USD | -0.87% | -14.71% | -17.79% | -35.47% | 1.10 B USD | ||
| 2384 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 10.50 USD | -2.96% | -2.33% | -21.64% | +20.00% | 1.01 B USD | ||
| 2398 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 15.46 USD | -1.09% | +4.74% | -27.86% | +137.85% | 994.92 M USD | ||
| 2401 |  SVRA Savara, Inc. - Common Stock | 4.83 USD | -1.02% | -5.29% | -11.86% | +40.41% | 992.37 M USD | ||
| 2404 |  IMTX Immatics N.V. - Ordinary Shares | 7.37 USD | -1.07% | -13.90% | -21.43% | -28.79% | 988.11 M USD | ||
| 2429 |  ANRO Alto Neuroscience, Inc. Common Stock | 24.02 USD | +2.08% | -7.97% | -32.85% | +289.30% | 942.60 M USD | ||
| 2434 |  KURA Kura Oncology, Inc. - Common Stock | 10.52 USD | -1.41% | -2.68% | -15.84% | +4.37% | 935.87 M USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |